Quality Improvement for Institutions
www.cvquality.acc.org

Cardiovascular Quality and Research News

ACC CV Quality SmartBrief

The ACC CV Quality SmartBrief eNewsletter is a free, twice-weekly briefing for health care stakeholders interested in quality care. Learn more about the ACC CV Quality SmartBrief and subscribe.

  • Controlling OR traffic to reduce infection risk

    Reducing surgical site infections involves addressing factors such as operating room traffic, use of personal protective equipment and interruptions in workflow. Opening OR doors can disrupt air pressure and increase particle counts, raising infection risks, researchers note. Infection Control Today (4/23) Learn More

  • Severity of hyponatremia linked to mortality risk

    Research in the European Journal of Internal Medicine found that patients with hyponatremia had higher 30-day mortality rates compared with those who had normal blood sodium levels. Data from more than 79,000 patients showed that the risk of mortality declined over time for those with mild hyponatremia. Medscape (4/22) Learn More

  • Universal avian influenza vaccine in the works

    DioSynVax and ACM Biolabs are collaborating to develop a universal avian influenza vaccine based on messenger RNA technology. The vaccine will target all major clades of the H5 subtype and may be available in nasal spray form to encourage uptake. Center for Infectious Disease Research and Policy (4/22) Learn More

  • Licensing law aims to address Ill. physician shortage

    An Illinois law has established a more streamlined licensing pathway for internationally trained physicians, allowing them to practice under supervision for two years in underserved areas and then receive provisional licenses for another two years before becoming fully licensed. The law aims to address a projected shortage of several thousand physicians in the state. Illinois Public Media (4/17) Learn More

  • Mount Sinai gains FDA nod for AI to spot cardiomyopathy

    Mount Sinai researchers have developed an AI algorithm to help physicians identify hypertrophic cardiomyopathy, receiving FDA approval for detection via electrocardiograms. The algorithm assigns a numeric probability risk assessment, aiming to improve clinical workflows by prioritizing high-risk patients. Becker's Hospital Review (4/22) Learn More

  • Study data support drug-eluting stent for PAD

    At a conference, Boston Scientific presented supporting data for the use of its Eluvia drug-eluting stent in the treatment of peripheral artery disease. A meta-analysis of 142 trials involving more than 52,000 patients found that Eluvia had superior primary patency rates as well as lower target lesion revascularization rates compared with other stents. A real-world study found that Eluvia significantly reduced amputation and readmission rates compared with bare device therapies. Drug Delivery Business News (4/23) Learn More

  • Digital health use on the rise in vulnerable US counties

    A study in JAMA Network Open shows a rise in digital health usage in US counties with high social vulnerability, particularly among Black and Hispanic populations. The study, conducted by the NIH and Information Management Services, surveyed 5,444 adults in 871 counties, finding higher use of telehealth, telemedicine and telemonitoring in more vulnerable areas. Digital health literacy and individual characteristics, such as education and mental health, significantly influenced usage. TechTarget (4/21) Learn More

Temp Styles

American College of Cardiology: 2400 N St. NW, Washington DC 20006